- 专利标题: Formulation and process for modulating wound healing
-
申请号: US17221181申请日: 2021-04-02
-
公开(公告)号: US11786481B2公开(公告)日: 2023-10-17
- 发明人: Chun-che Tsai , Karen M. McGuire , James M. Jamison , Jack L. Summers
- 申请人: BioMendics, LLC
- 申请人地址: US OH Fairlawn
- 专利权人: BioMendics, LLC
- 当前专利权人: BioMendics, LLC
- 当前专利权人地址: US OH Fairlawn
- 代理机构: MacMillan, Sobanski & Todd, LLC
- 主分类号: A61K31/05
- IPC分类号: A61K31/05 ; A61K31/085 ; A61K31/09 ; A61K31/7034 ; A61K45/06 ; A61K9/06 ; A61K47/36 ; A61K47/40 ; A61Q19/08 ; A61Q7/00 ; A61K8/34 ; A61K8/33 ; A61K8/60 ; A61K8/73 ; A61K8/67 ; A61K9/00 ; A61K9/08 ; A61K9/19 ; A61K8/70 ; A61K31/03 ; A61K31/167 ; A61K31/375 ; A61K31/655
摘要:
Methods and compounds are disclosed for wound healing by modulating autophagy. A formulation for modulating autophagy comprises a first modulating compound (FAM) selected from compounds having the general structure (I):
wherein: L represents a linker selected from —C≡C—, (a tolan), —CH═CH— (a stilbene, preferably trans); or —CRa═CRb— a stilbene derivative; where Ra and Rb are independently H or phenyl optionally substituted with —(R3)p or —(R4)q;
R1 to R4 are independent substituents at any available position of the phenyl rings, preferably at 3, 3′, 4, 4′, and/or 5, 5′; and m, n, p, and q are independently 0, 1, 2, or 3 representing the number of substituents of the rings, respectively, but at least one of m or n must be ≥1. Each R1 to R2 is independently selected from substituents described herein, including but not limited to hydroxyl, alkoxy, halo, halomethyl and glycosides. The formulation may also include an auxiliary autophagy modulating compound (AAM) as described herein. The formulation may include a hydrogel formed by the compounds themselves or otherwise and may include salts and/or complexes.
wherein: L represents a linker selected from —C≡C—, (a tolan), —CH═CH— (a stilbene, preferably trans); or —CRa═CRb— a stilbene derivative; where Ra and Rb are independently H or phenyl optionally substituted with —(R3)p or —(R4)q;
R1 to R4 are independent substituents at any available position of the phenyl rings, preferably at 3, 3′, 4, 4′, and/or 5, 5′; and m, n, p, and q are independently 0, 1, 2, or 3 representing the number of substituents of the rings, respectively, but at least one of m or n must be ≥1. Each R1 to R2 is independently selected from substituents described herein, including but not limited to hydroxyl, alkoxy, halo, halomethyl and glycosides. The formulation may also include an auxiliary autophagy modulating compound (AAM) as described herein. The formulation may include a hydrogel formed by the compounds themselves or otherwise and may include salts and/or complexes.
公开/授权文献
- US20210228501A1 Formulation and Process for Modulating Wound Healing 公开/授权日:2021-07-29
信息查询